• Develops devices that electronically measure blood pressure, heart rate, activity levels, and blood oxygen saturation levels using photoplethysmography and electrocardiography
  • Device and mobile application currently still in development; company is targeting a 2017 launch
  • Targets enterprises ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research


Company Snapshot | July 01, 2021

The company was founded by Ben Moga, Erwin Berthier, and Ben Casavant in 2012. To date, the company has raised approximately $35.6 million, most recently through a $17 million Series A round in July 2020. Among its investors, we highlight Cedar‑Sinai Accelerator, Merck Global Health Innovation Fund... Not part of subscription

Common Sensing

Company Profile | March 21, 2022

Common Sensing develops smart caps to provide connectivity to injectable‑medicine pens, most commonly insulin pens for diabetes patients It uses optical sensors to monitor the volume of liquid medication in a pen and automatically logs dosing events and the amount of medication injected to ... Not part of subscription


Company Profile | May 19, 2022

Develops a smartwatch and app that monitor blood glucose levels to help support diabetics through its subsidiary PKvitality Claims differentiation in the ability to detect glucose in the body, while also monitoring calories, steps, and distance, but faces competition from other smartwatches and... Not part of subscription